The Library
Efficacy of high-volume injections with and without corticosteroid compared with sham for Achilles tendinopathy : a protocol for a randomised controlled trial
Tools
Tools
Tools
Malliaras, Peter, Connell, David, Boesen, Anders Ploug, Kearney, Rebecca S., Menz, Hylton B., Morrissey, Dylan, Munteanu, Shannon E., Silbernagel, Karin G., Underwood, Martin and Haines, Terry P. (2021) Efficacy of high-volume injections with and without corticosteroid compared with sham for Achilles tendinopathy : a protocol for a randomised controlled trial. BMJ Open Sport & Exercise Medicine, 7 (4). e001136. doi:10.1136/bmjsem-2021-001136
|
PDF
WRAP-efficacy-high-volume-injections-with-without-corticosteroid-compared-sham-Achilles-tendinopathy-2022.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons: Attribution-Noncommercial 4.0. Download (938Kb) | Preview |
Official URL: https://doi.org/10.1136/bmjsem-2021-001136
Abstract
Introduction: Achilles tendinopathy (AT) is a common and disabling musculoskeletal condition. First-line management involving Achilles tendon loading exercise with, or without, other modalities may not resolve the problem in up to 44% of cases. Many people receive injections. Yet there are no injection treatments with demonstrated long-term efficacy. The aim of the trial is to examine the 12-month efficacy of high-volume injection (HVI) with corticosteroid and HVI without corticosteroid versus sham injection among individuals with AT. Methods and analysis: The trial is a three-arm, parallel group, double-blind, superiority randomised controlled trial that will assess the efficacy of HVI with and without corticosteroid versus sham up to 12 months. We will block-randomise 192 participants to one of the three groups with a 1:1:1 ratio, and both participants and outcome assessors will be blinded to treatment allocation. All participants will receive an identical evidence-based education and exercise intervention. The primary outcome measure will be the Victorian Institute of Sport Assessment – Achilles (VISA-A) at 12 months post-randomisation, a validated, reliable and disease-specific measure of pain and function. Choice of secondary outcomes was informed by core outcome domains for tendinopathy. Data will be analysed using the intention-to-treat principle. Ethics and dissemination: Ethics approval was obtained via the Monash University Human Ethics Committee (no: 13138). The study is expected to be completed in 2024 and disseminated via peer review publication and conference presentations. Trial registration number: Australia and New Zealand Clinical trials registry (ACTRN12619001455156)
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QP Physiology R Medicine > RC Internal medicine R Medicine > RD Surgery R Medicine > RM Therapeutics. Pharmacology |
||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||
| SWORD Depositor: | Library Publications Router | ||||||
| Library of Congress Subject Headings (LCSH): | Achilles tendon -- Wounds and injuries, Achilles tendon -- Wounds and injuries -- Treatment, Injections , Adrenocortical hormones , Sports medicine | ||||||
| Journal or Publication Title: | BMJ Open Sport & Exercise Medicine | ||||||
| Publisher: | BMJ Publishing Group | ||||||
| ISSN: | 2055-7647 | ||||||
| Official Date: | 22 October 2021 | ||||||
| Dates: |
|
||||||
| Volume: | 7 | ||||||
| Number: | 4 | ||||||
| Article Number: | e001136 | ||||||
| DOI: | 10.1136/bmjsem-2021-001136 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Open Access | ||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
